Table 1.
Characteristics | All Patients (n = 35) |
---|---|
Age (years ± SD) | 55.8 ± 12.5 |
Gender (%) | |
Male | 32 (91) |
Female | 3 (9) |
Smoking (%) | |
Never | 9 (26) |
Past and present | 26 (74) |
Alcohol (%) | |
Never | 15 (43) |
Past and present | 20 (57) |
Tumor stage (%) | |
T1–2 (early) | 8 (23) |
T3–4 (advanced) | 27 (77) |
Lymph node metastasis (%) | |
N0 (negative) | 4 (11) |
N1–3 (positive) | 31 (89) |
Metastasis (%) | |
M0 (negative) | 33 (94) |
M1 (positive) | 2 (6) |
Stage (%) | |
I–II (early) | 8 (23) |
III–IV (advanced) | 27 (77) |
Histology (WHO Type) | |
Keratinizing squamous cell carcinoma | 0 (0) |
Non-keratinizing carcinomaDifferentiated type | 21 (60) |
Non-keratinizing carcinomaUndifferentiated type | 14 (40) |
Recurrent outcomes (%) | |
No recurrence | 22 (63) |
Recurrence | 13 (37) |
PFS (mean month ± SD) | 34.3 ± 28.5 |
OS (mean month ± SD) | 49.5 ± 31 |
NPC, nasopharyngeal carcinoma; SD, standard deviation; PFS, progression-free survival; OS, overall survival.